Offloading—the redistribution of mechanical pressure away from a wound—is one of the most consistently effective interventions in diabetic foot care, yet it remains among the most underused. Plantar diabetic foot ulcers develop where repetitive pressure meets the insensate foot of a person with peripheral neuropathy. No matter how meticulous the wound dressing or how well controlled the blood glucose, an ulcer subjected to continued weight-bearing trauma will struggle to close. Understanding why pressure relief matters, and which devices actually deliver it, is central to evidence-based wound healing.
Why Pressure Relief Drives Healing
In a foot affected by diabetic peripheral neuropathy, the protective sensation that would normally prompt a person to limp, shift weight, or rest is diminished or absent. Each step delivers unmitigated force to the ulcer bed, disrupting the fragile cellular activity required for tissue repair. Offloading interrupts this cycle by transferring load to other areas of the foot and lower leg, allowing the wound bed to granulate and re-epithelialize.
The strength of the evidence reflects this mechanism. A 2024 meta-analysis of randomized controlled trials conducted for the Italian diabetic foot guidelines found that any plantar offloading device, compared with no offloading, was associated with significantly higher odds of ulcer healing (odds ratio 3.13). The same analysis showed that surgical offloading of an active ulcer, combined with post-surgical offloading, produced even higher healing rates (odds ratio 6.77) in selected cases (Gauna et al., Acta Diabetologica, 2024).
The Hierarchy of Offloading Devices
Not all offloading is equal. The total contact cast (TCC)—a well-molded, minimally padded cast that conforms to the entire plantar surface and lower leg—is widely regarded as the gold standard for offloading non-infected, non-ischemic neuropathic plantar ulcers. Its defining feature is that it is non-removable: the patient cannot take it off, which guarantees that pressure relief is maintained throughout the day.
Non-removable versus removable
The clinical importance of non-removability is well documented. A 2024 meta-analysis found that total contact casts or non-removable knee-high walkers achieved significantly higher healing rates than other offloading devices (odds ratio 2.64) (Gauna et al., Acta Diabetologica, 2024). A secondary analysis comparing TCCs with removable cast walker boots reported that 93% of ulcers healed with the TCC versus 65% with the removable device, with mean healing times of 77 days compared with 138 days. Crucially, patients in removable devices took more daily steps—suggesting that the ability to remove a device translates into more weight-bearing on the wound and slower healing (Wendland et al., Advances in Skin & Wound Care, 2023).
A rapid review with meta-analysis and trial sequential analysis similarly found that non-removable fiberglass total contact casting was associated with a shorter healing time than removable cast walkers, although the authors noted that the overall evidence base remains modest and calls for further rigorous trials (Okoli et al., BMJ Open Diabetes Research & Care, 2022). A separate systematic review of fourteen controlled trials reached the same conclusion: the total contact cast was the most effective offloading method, even accounting for its practical drawbacks (Velasco-Rodríguez-Rabadán et al., The International Journal of Lower Extremity Wounds, 2023).
A Persistent Gap Between Evidence and Practice
Despite consistent findings, gold-standard offloading is markedly underused in everyday practice. A survey of Swedish prosthetic and orthotic clinics found that 86% of practitioners treated neuropathic forefoot ulcers with modified off-the-shelf footwear and insoles—the very approach that international guidelines recommend against—while only 20% offered total contact casting and none used a non-removable knee-high walker. Many practitioners were unaware that these were the recommended first-line devices. The authors described the resulting pattern of care as “almost exactly opposite” to evidence-based recommendations (Gigante et al., Diabetes/Metabolism Research and Reviews, 2023).
The reasons for this gap are practical rather than scientific. Total contact casts require training and time to apply, prevent daily inspection of the wound, and are contraindicated in significant peripheral arterial disease or infection. Clinicians often default to removable devices for convenience or to allow wound monitoring, accepting slower healing as a trade-off. Innovations such as windowed casts that permit wound access, and instant total contact casts that render a removable walker effectively non-removable, aim to bridge this divide while preserving the offloading benefit.
Clinical Takeaways
The 2023 guidelines of the International Working Group on the Diabetic Foot, developed using a structured evidence-to-decision framework, reaffirm offloading as a core pillar of diabetic foot ulcer management (Bus et al., Diabetes/Metabolism Research and Reviews, 2023). The consistent message across the literature is that for a non-infected, non-ischemic neuropathic plantar ulcer, a non-removable knee-high device—the total contact cast or an equivalent—offers the best prospect of timely healing. Removable devices are a reasonable second choice when non-removable casting is contraindicated or impractical, but their effectiveness depends heavily on patient adherence. Recognizing this hierarchy, and the everyday barriers that lead clinicians away from it, is essential to closing the gap between what the evidence supports and what patients actually receive.
References
Bus SA, Monteiro-Soares M, Game F, et al. Standards for the development and methodology of the 2023 IWGDF guidelines. Diabetes/Metabolism Research and Reviews. 2023;40(3):e3656.
Gauna C, Romeo F, Scatena A, et al. Offloading systems for the treatment of neuropathic foot ulcers in patients with diabetes mellitus: a meta-analysis of randomized controlled trials for the development of the Italian guidelines for the treatment of diabetic foot syndrome. Acta Diabetologica. 2024;61(6):693–703.
Wendland DM, Kline PW, Bohnert KL, Biven TM, Sinacore DR. Offloading of diabetic neuropathic plantar ulcers: secondary analysis of step activity and ulcer healing. Advances in Skin & Wound Care. 2023;36(4):194–200.
Okoli GN, Rabbani R, Lam OLT, et al. Offloading devices for neuropathic foot ulcers in adult persons with type 1 or type 2 diabetes: a rapid review with meta-analysis and trial sequential analysis of randomized controlled trials. BMJ Open Diabetes Research & Care. 2022;10(3):e002822.
Velasco-Rodríguez-Rabadán S, Tardáguila-García A, Sanz-Corbalán I, García-Madrid M, López-Moral M, Lázaro-Martínez JL. Effectiveness of off-loading devices in patients with active diabetic foot ulcer: a systematic review. The International Journal of Lower Extremity Wounds. 2023;24(4):887–893.
Gigante I, Sigurjónsdóttir ED, Jarl G, Hellstrand Tang U. Offloading of diabetes-related neuropathic foot ulcers at Swedish prosthetic and orthotic clinics. Diabetes/Metabolism Research and Reviews. 2023;39(4):e3611.
Comments
